{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:27:34Z","timestamp":1793899654962,"version":"4.8.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T00:00:00Z","timestamp":1558396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.biopha.2019.109024","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T06:26:35Z","timestamp":1559024795000},"page":"109024","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Naproxenylamino acid derivatives: Design, synthesis, docking, QSAR and anti-inflammatory and analgesic activity"],"prefix":"10.1016","volume":"116","author":[{"given":"Ahmed. A.","family":"Elhenawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.M.","family":"AL-Harbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"El-Gazzar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal M.","family":"Khowdiary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnane","family":"ouidate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer M.","family":"Alosaimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abd","family":"elhamid Salim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.biopha.2019.109024_bib0005","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0006-2952(02)00842-0","article-title":"Selective cyclooxygenase-2 (COX-2) inhibitors and potential risk of cardiovascular events","volume":"63","author":"Mukherjee","year":"2002","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2019.109024_bib0010","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/gut.2004.047100","article-title":"Prostaglandins and cancer","volume":"55","author":"Wang","year":"2006","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.biopha.2019.109024_bib0015","first-page":"69","article-title":"Synthesis, anti-infammatory, analgesic, molecular modeling and ADMET studies of novel diclofenac derivatives containing alanyl moiety","volume":"6","author":"Elhenawy","year":"2014","journal-title":"Chem. Mater. Res."},{"issue":"1","key":"10.1016\/j.biopha.2019.109024_bib0020","first-page":"1","article-title":"Synthesis, anti-in\ufb02ammatory, analgesic, molecular modeling and admet studies of novel diclofenac derivatives containing leucinyl moiety","volume":"1","author":"Elhenawy","year":"2013","journal-title":"Int. J. Chem. Mater. Res."},{"key":"10.1016\/j.biopha.2019.109024_bib0025","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.saa.2019.02.074","article-title":"Synthesis, molecular properties and comparative docking and QSAR of new 2-(7-hydroxy-2-oxo-2H-chromen-4-yl) acetic acid derivatives as possible anticancer agents","volume":"218","author":"Elhenawy","year":"2019","journal-title":"Spectrochim. Acta A. Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.biopha.2019.109024_bib0030","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.biopha.2018.02.122","article-title":"Synthesis and antinociceptive evaluation of bioisosteres and hybrids of naproxen, ibuprofen and paracetamol","volume":"101","author":"Gonz\u00e1lez-Trujano","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"1-6","key":"10.1016\/j.biopha.2019.109024_bib0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0928-4257(01)00003-1","article-title":"Role of cyclooxygenase isoforms in gastric mucosal defence","volume":"95","author":"Peskar","year":"2001","journal-title":"J. Physiol. Paris"},{"issue":"12","key":"10.1016\/j.biopha.2019.109024_bib0040","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1200\/JCO.2005.09.051","article-title":"COX-2: a molecular target for colorectal cancer prevention","volume":"23","author":"Brown","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2019.109024_bib0045","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/onc.2009.421","article-title":"The role of COX-2 in intestinal inflammation and colorectal cancer","volume":"29","author":"Wang","year":"2010","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.biopha.2019.109024_bib0050","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.canlet.2010.03.015","article-title":"Cyclooxygenase-2 in tumorigenesis of gastrointestinal cancers: an update on the molecular mechanisms","volume":"295","author":"Wu","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2019.109024_bib0055","article-title":"Drugs for cough and bronchial asthma","volume":"vol. 196","author":"Tripathi","year":"2004"},{"issue":"1","key":"10.1016\/j.biopha.2019.109024_bib0060","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/10837450903460475","article-title":"Preparation, in vitro characterization and in vivo release of naproxen loaded in poly-caprolactone nanoparticles","volume":"16","author":"Rodrigues","year":"2011","journal-title":"Pharm. Dev. Technol."},{"issue":"5","key":"10.1016\/j.biopha.2019.109024_bib0065","first-page":"513","article-title":"Amide Derivatives of sulfonamides and isoniazid: synthesis and biological evaluationn","volume":"66","author":"Husain","year":"2009","journal-title":"Acta Pol. Pharm. Drug Res."},{"issue":"6","key":"10.1016\/j.biopha.2019.109024_bib0070","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1747-0285.2009.00811.x","article-title":"Convenient synthesis of ibuprofen and naproxen aminoacyl, dipeptidoyl and ester derivatives","volume":"73","author":"Katritzky","year":"2009","journal-title":"Chem. Biol. Drug Des."},{"issue":"7-8","key":"10.1016\/j.biopha.2019.109024_bib0075","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0223-5234(00)80025-2","article-title":"Cyclic amide derivatives as potential prodrugs II: N-hydroxymethylsuccinimide-\/isatin esters of some NSAIDs as prodrugs with an improved therapeutic index","volume":"34","author":"Mahfouz","year":"1999","journal-title":"Eur. J. Med. Chem."},{"issue":"15","key":"10.1016\/j.biopha.2019.109024_bib0080","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1080\/00397911.2017.1328066","article-title":"Naproxen derivatives: synthesis, reactions, and biological applications","volume":"47","author":"Ammar","year":"2017","journal-title":"Synth. Commun."},{"issue":"8","key":"10.1016\/j.biopha.2019.109024_bib0085","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1016\/j.bmc.2005.11.040","article-title":"Synthesis and anti-inflammatory activity of a series of N-substituted naproxen glycolamides: nitric oxide-donor naproxen prodrugs","volume":"14","author":"Ranatunge","year":"2006","journal-title":"Bioorg. Med. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2019.109024_bib0090","first-page":"553","article-title":"Computer aided discovery of potential anti-inflammatory (s)-naproxen analogs as COX-2 inhibitors","volume":"9","author":"Manjunathaiah Raghavendra","year":"2013","journal-title":"Med. Chem. (Los Angeles)"},{"issue":"9","key":"10.1016\/j.biopha.2019.109024_bib0095","first-page":"4491","article-title":"Synthesis, anti-inflammatory and antimicrobial activity of some novel carboxamide derivatives of naproxen","volume":"18","author":"Fernandes","year":"2013","journal-title":"J. Mol. Model."},{"issue":"2","key":"10.1016\/j.biopha.2019.109024_bib0100","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0304-3835(03)00472-5","article-title":"Naproxen, clenbuterol and insulin administration ameliorates cancer cachexia and reduce tumor growth in Walker 256 tumor-bearing rats","volume":"201","author":"Piffar","year":"2003","journal-title":"Cancer Lett."},{"issue":"9","key":"10.1016\/j.biopha.2019.109024_bib0105","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.1016\/j.bmc.2008.03.050","article-title":"Synthesis and structure\u2013activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group","volume":"16","author":"Chen","year":"2008","journal-title":"Bioorg. Med. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2019.109024_bib0110","first-page":"1552","article-title":"Design and synthesis, of some novel 6-methoxynaphthalene derivatives with potential anti-cancer activity","volume":"4","author":"Khalifa","year":"2012","journal-title":"Der Pharm. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2019.109024_bib0115","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1128\/AAC.02335-12","article-title":"Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus","volume":"57","author":"Lejal","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2019.109024_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2014.05.003","article-title":"Structure\u2013activity relationships and molecular modelling of new 5-arylidene-4-thiazolidinone derivatives as aldose reductase inhibitors and potential anti-inflammatory agents","volume":"81","author":"Maccari","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"7061","key":"10.1016\/j.biopha.2019.109024_bib0125","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nature04051","article-title":"Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus","volume":"437","author":"Mygind","year":"2005","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.biopha.2019.109024_bib0130","first-page":"597","article-title":"Antimicrobial peptides: properties and applicability","volume":"382","author":"van t Hof","year":"2001","journal-title":"Biol. Chem."},{"key":"10.1016\/j.biopha.2019.109024_bib0135","first-page":"78","article-title":"Computational elucidation of structural basis for ligand binding with Leishmania donovani adenosine kinase","volume":"83","author":"Kar","year":"2013","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2019.109024_bib0140","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ijbiomac.2015.11.051","article-title":"Establishment of correlation between in-silico and in-vitro test analysis against Leishmania HGPRT to inhibitors","volume":"83","author":"Ansari","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.biopha.2019.109024_bib0145","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/(SICI)1097-0134(19991101)37:2<228::AID-PROT8>3.0.CO;2-8","article-title":"Evaluation of the FLEXX incremental construction algorithm for protein\u2013ligand docking","volume":"37","author":"Kramer","year":"1999","journal-title":"Proteins Struct. Funct. Bioinform."},{"issue":"3","key":"10.1016\/j.biopha.2019.109024_bib0150","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3181\/00379727-111-27849","article-title":"Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs","volume":"111","author":"Winter","year":"1962","journal-title":"Exp. Biol. Med."},{"issue":"7","key":"10.1016\/j.biopha.2019.109024_bib0155","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/j.1440-1746.2009.05929.x","article-title":"Rescue strategies against non\u2010steroidal anti\u2010inflammatory drug\u2010induced gastroduodenal damage","volume":"24","author":"Lim","year":"2009","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2019.109024_bib0160","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejphar.2017.03.021","article-title":"Low doses of tizanidine synergize the anti-nociceptive and anti-inflammatory effects of ketorolac or naproxen while reducing of side effects","volume":"805","author":"Pati\u00f1o-Camacho","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2019.109024_bib0165","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0022-3565(25)03823-6","article-title":"A method for determining loss of pain sensation","volume":"72","author":"D\u2019Amour","year":"1941","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2019.109024_bib0170","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s11135-006-9018-6","article-title":"A caution regarding rules of thumb for variance inflation factors","volume":"41","author":"O\u2019brien","year":"2007","journal-title":"Qual. Quant."},{"issue":"14","key":"10.1016\/j.biopha.2019.109024_bib0175","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function","volume":"19","author":"Morris","year":"1998","journal-title":"J. Comput. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2019.109024_bib0180","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.biopha.2019.109024_bib0185","series-title":"\"BIOVIA, Discovery Studio Modeling Environment\"","author":"Dassault","year":"2017"},{"issue":"1","key":"10.1016\/j.biopha.2019.109024_bib0190","first-page":"82","article-title":"\"Pymol: an open-source molecular graphics tool\"","volume":"40","author":"DeLano","year":"2002","journal-title":"CCP4 Newslett. Prot. Crystallogr."},{"issue":"11","key":"10.1016\/j.biopha.2019.109024_bib0195","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nchembio.663","article-title":"(R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2","volume":"7","author":"Duggan","year":"2011","journal-title":"Nat. Chem. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2019.109024_bib0200","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1359-6446(99)01451-8","article-title":"Computational methods for the prediction of drug-likeness","volume":"5","author":"Clark","year":"2000","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biopha.2019.109024_bib0205","series-title":"1010 Handbook St. West, Suite 910, Montreal, QC, Canada, H3A 2R7","author":"Molecular Operating Environment (MOE)","year":"2017"},{"issue":"5-6","key":"10.1016\/j.biopha.2019.109024_bib0210","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/(SICI)1096-987X(199604)17:5\/6<490::AID-JCC1>3.0.CO;2-P","article-title":"Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94","volume":"17","author":"Halgren","year":"1996","journal-title":"J. Comput. Chem."},{"issue":"7","key":"10.1016\/j.biopha.2019.109024_bib0215","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/jcc.21707","article-title":"PaDEL\u2010descriptor: an open source software to calculate molecular descriptors and fingerprints","volume":"32","author":"Yap","year":"2011","journal-title":"J. Comput. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2019.109024_bib0220","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1021\/ci980405r","article-title":"Development and validation of a novel variable selection technique with application to multidimensional quantitative structure\u2212 activity relationship studies","volume":"39","author":"Waller","year":"1999","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.biopha.2019.109024_bib0225","first-page":"113","article-title":"Pharmacological research on gefarnate, a new synthetic isoprenoid with an anti-ulcer action","volume":"147","author":"Adami","year":"1964","journal-title":"Arch. Int. Pharmacodyn. Th\u00e9r."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219310492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219310492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T16:56:18Z","timestamp":1793897778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332219310492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":45,"alternative-id":["S0753332219310492"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109024","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Naproxenylamino acid derivatives: Design, synthesis, docking, QSAR and anti-inflammatory and analgesic activity","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"109024"}}